Jul 19, 2018
Comparative benefits and harms of basal insulin analogues for type 2 diabetes: A systematic review and network meta-analysis
Circulating vitamin D and colorectal cancer risk: An international pooling project of 17 cohorts
Long-term survival of young patients surviving ICU admission with severe sepsis
3 reasons to join M3 India Market Research Panel
- Contribute to improvements in Healthcare by sharing your insights
- Earn rewards in your free time
- Secure: We never share your personal information without your permission
Over 4 million Doctors across 9 countries
trust M3 Group for their daily practice.
M3 India is a Joint Venture between M3 Inc. Japan and Health Care at Home India Pvt. Ltd.
By leveraging internet based technologies, this initiative will expand access to information and enhance communication in the Indian healthcare sector.